Please wait while the transcript is being prepared...
0:00
Hello, my name is Michaela Kneissel.
And I'm based at the
Novartis Institutes
for BioMedical Research
in Switzerland.
I'm going to talk today
about some of the pathways
which control bone formation.
0:13
I will start off with a brief
introduction to bone homeostasis
before speaking about three pathways
which regulate bone formation.
I choose to highlight those out
of the range of relevant pathways,
as they are the major pathways
targeted to date for the treatment
of bone diseases and injuries.
First and foremost, I will
introduce you to Wnt signaling,
its crucial role in
bone formation, and how
the pathway is currently targeted
for the treatment of bone fragility.
In particular, I will spend some
time explaining the role and
mode of action of the Wnt
antagonist sclerostin
which is a key negative
regulator of bone formation.
I will then also introduce briefly
the impact of parathyroid hormone,
or PTH signaling on
bone formation, and how
it is used to treat osteoporosis.
Finally, I will touch on
the importance of bone
morphogenetic protein,
or BMP signaling,
and how its modulation can be
used to promote bone healing
or hinder excessive formation.
And I will highlight some
of the cross-talk that exists
between these three
pathways and the regulation
of bone homeostasis.
1:25
The skeleton contains three major
cell types-- osteoblasts and the
derived osteocytes and osteoclasts.
Osteoblasts form bone.
Osteoclasts resorb bone.
And osteocytes maintain bone and
contribute to the regulation of
osteoblast and osteoclast activity.
